ATE450622T1 - Gene und proteine für verhinderung, vorhersage, prognose und therapie der herzgefäss-krankheit - Google Patents
Gene und proteine für verhinderung, vorhersage, prognose und therapie der herzgefäss-krankheitInfo
- Publication number
- ATE450622T1 ATE450622T1 AT02777275T AT02777275T ATE450622T1 AT E450622 T1 ATE450622 T1 AT E450622T1 AT 02777275 T AT02777275 T AT 02777275T AT 02777275 T AT02777275 T AT 02777275T AT E450622 T1 ATE450622 T1 AT E450622T1
- Authority
- AT
- Austria
- Prior art keywords
- genes
- cardiovascular disease
- prognosis
- prediction
- prevention
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 208000024172 Cardiovascular disease Diseases 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 2
- 238000004393 prognosis Methods 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 210000004204 blood vessel Anatomy 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0124145.4A GB0124145D0 (en) | 2001-10-08 | 2001-10-08 | Genes and proteins for prevention,prediction,prognosis and therapy of cardiovascular disease |
| PCT/EP2002/011034 WO2003031650A2 (en) | 2001-10-08 | 2002-10-02 | Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE450622T1 true ATE450622T1 (de) | 2009-12-15 |
Family
ID=9923436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02777275T ATE450622T1 (de) | 2001-10-08 | 2002-10-02 | Gene und proteine für verhinderung, vorhersage, prognose und therapie der herzgefäss-krankheit |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1436425B1 (de) |
| AT (1) | ATE450622T1 (de) |
| AU (1) | AU2002338852A1 (de) |
| DE (1) | DE60234619D1 (de) |
| GB (1) | GB0124145D0 (de) |
| WO (1) | WO2003031650A2 (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1448600A4 (de) | 2001-09-07 | 2004-12-22 | Bristol Myers Squibb Co | Für einen neuen menschlichen g-protein-gekoppelten rezeptor hgprbmy39 codierendes polynukleotid |
| JP2007503806A (ja) * | 2003-08-29 | 2007-03-01 | アンテグラジャン | ヒト肥満感受性遺伝子およびその使用 |
| EP1522857A1 (de) | 2003-10-09 | 2005-04-13 | Universiteit Maastricht | Methode zur Feststellung des Risikos von Herzversagen in einem Individuum durch Bestimmung der Menge an Galectin-3 oder Thrombospondin-2 |
| WO2005095641A1 (en) * | 2004-03-03 | 2005-10-13 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with mitogen-activated protein kinase kinase kinase 11 (map3k11) |
| JP4885861B2 (ja) | 2004-10-04 | 2012-02-29 | ユニヴァーシティ オブ ワシントン | 哺乳動物における細胞死または炎症を阻害する方法 |
| US20110021433A1 (en) * | 2004-10-04 | 2011-01-27 | Harlan John M | Methods for treating or preventing heart failure |
| US8648045B2 (en) | 2005-03-10 | 2014-02-11 | Ben Gurion University Of The Negev Research And Development Authority Ltd. | VDAC1 compositions and methods of use thereof for regulating apoptosis |
| US8119601B2 (en) | 2005-03-10 | 2012-02-21 | Ben-Gurion University Of The Negev Research And Development Authority Ltd. | Voltage dependent anion channel (VDAC1) compositions and methods of use thereof for regulating apoptosis |
| US8093369B2 (en) | 2005-10-11 | 2012-01-10 | Ben Gurion University Of The Negev Research And Development Authority Ltd. | Compositions for silencing the expression of VDAC1 and uses thereof |
| US8815519B2 (en) | 2006-12-22 | 2014-08-26 | Hvidovre Hospital | Method for predicting cancer and other diseases |
| US7550300B1 (en) | 2007-11-29 | 2009-06-23 | Capgen Sciences, Inc. | Prediction of bare metal stent restenosis |
| NZ586746A (en) * | 2008-01-23 | 2012-07-27 | Righospitalet | Classification of individuals suffering from cardiovascular diseases according to survival prognoses as found by measuring the levels of biomarker ykl-40 |
| WO2010037181A1 (en) * | 2008-10-03 | 2010-04-08 | The Walter And Eliza Hall Institute Of Medical Research | Cell therapy and compositions therefor |
| EA201270316A1 (ru) | 2009-08-25 | 2012-09-28 | БиДжи МЕДИСИН, ИНК. | Галектин-3 и сердечная ресинхронизирующая терапия |
| WO2015011711A1 (en) | 2013-07-25 | 2015-01-29 | The National Institute for Biotechnology in the Negev Ltd. | Short peptides derived from vdac1, compositions and methods of use thereof |
| WO2017027422A1 (en) | 2015-08-07 | 2017-02-16 | Alexo Therapeutics Inc. | Constructs having a sirp-alpha domain or variant thereof |
| EP3373939A4 (de) | 2015-11-10 | 2019-06-26 | B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University | Mittel und verfahren zur verringerung der tumorigenität von krebsstammzellen |
| PL3658589T3 (pl) | 2017-07-26 | 2024-03-18 | Forty Seven, Inc. | Przeciwciała anty-sirp-alfa i powiązane sposoby |
| KR20220044904A (ko) | 2019-05-31 | 2022-04-12 | 알렉소 온콜로지 인크. | 면역 관문 억제제와 병용하는 sirp 알파 fc 융합으로 암을 치료하는 방법 |
| CN114845710A (zh) | 2019-11-27 | 2022-08-02 | Alx肿瘤生物技术公司 | 用于治疗癌症的组合疗法 |
| BR112023022774A2 (pt) | 2021-05-13 | 2024-01-02 | Alx Oncology Inc | Terapias de combinação para tratamento de câncer |
| WO2024137306A1 (en) * | 2022-12-22 | 2024-06-27 | University Of Utah Research Foundation | Compositions and methods for treating diabetic cardiomyopathy |
| WO2025240625A1 (en) * | 2024-05-15 | 2025-11-20 | University Of Utah Research Foundation | Cbin1 therapy improves atrial electrical and functional remodeling, limiting atrial arrhythmias in failing hearts |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991005793A1 (en) * | 1989-10-18 | 1991-05-02 | The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce | Production and use of human nm23 protein and antibodies therefor |
| GB0007268D0 (en) * | 2000-03-24 | 2000-05-17 | Cyclacel Ltd | Cell cycle progression proteins |
-
2001
- 2001-10-08 GB GBGB0124145.4A patent/GB0124145D0/en not_active Ceased
-
2002
- 2002-10-02 DE DE60234619T patent/DE60234619D1/de not_active Expired - Lifetime
- 2002-10-02 WO PCT/EP2002/011034 patent/WO2003031650A2/en not_active Ceased
- 2002-10-02 AU AU2002338852A patent/AU2002338852A1/en not_active Abandoned
- 2002-10-02 AT AT02777275T patent/ATE450622T1/de not_active IP Right Cessation
- 2002-10-02 EP EP02777275A patent/EP1436425B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE60234619D1 (de) | 2010-01-14 |
| AU2002338852A1 (en) | 2003-04-22 |
| GB0124145D0 (en) | 2001-11-28 |
| WO2003031650A3 (en) | 2004-02-12 |
| EP1436425B1 (de) | 2009-12-02 |
| WO2003031650A2 (en) | 2003-04-17 |
| EP1436425A2 (de) | 2004-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60234619D1 (de) | Gene und proteine für verhinderung, vorhersage, prognose und therapie der herzgefäss-krankheit | |
| HUP0303917A2 (hu) | Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére | |
| EP1900827A3 (de) | Verfahren und Zusammensetzungen zur Vorhersage, Diagnose, Prognose, Verhinderung und Behandlung maligner Neoplasien | |
| EP2006298A3 (de) | Jugendliches Hämochromatose-Gen (HFE2A), Expressionsprodukte und Verwendungen davon | |
| UA86344C2 (ru) | Способ лечения сосудистых заболеваний | |
| MXPA03009772A (es) | Metodos y composiciones para tratar lesiones orales y del esofago. | |
| EP1583504A4 (de) | Verfahren und zusammensetzungen für diagnose, prognose und behandlung von krebs | |
| EP1790728A3 (de) | Bildgebende Verfahren, Diagnose und Behandlung von Krankheiten | |
| TW200640944A (en) | VGF polypeptides and methods of treating VGF-related disorders | |
| MXPA02000680A (es) | Polipeptidos vgf y metodos para tratar desordenes relacionados con vgf. | |
| TR200200278T2 (tr) | Kalsilitik bileşimler | |
| DE60221352D1 (de) | Zusammensetzung und kit zur verwendung in der tumorbehandlung | |
| GB0300718D0 (en) | Proteins | |
| WO2003027633A3 (en) | Identifying drugs for and diagnosis of benign prostatic hyperplasia using gene expression profiles | |
| WO2006037485A3 (en) | Methods and kits for the prediction of therapeutic success and recurrence free survival in cancer therapy | |
| WO2004111270A3 (en) | Differential gene expression in schizophrenia | |
| WO2002097127A3 (en) | Genes and proteins for prevention, prediction, diagnosis, prognosis and treatment of chronic lung disease | |
| NO20060781L (no) | Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser | |
| ATE546548T1 (de) | Verfahren zur prognose des nutzens einer antioxidationshemmenden therapie zur vorbeugung von herz-kreislauf-erkrankungen bei hyperglykämischen patienten | |
| WO2005108605A3 (en) | Polymorphisms in abcb1 associated with a lack of clinical response to medicaments | |
| ATE341323T1 (de) | Verwendung von darifenacin zur behandlung des harndrangs | |
| ATE374260T1 (de) | Asthma-assoziiertes gen | |
| NZ514691A (en) | Method to type prion proteins | |
| IL169256A0 (en) | Metalloprotease proteins | |
| WO2001016158A3 (en) | Bridging integrator-2 (bin2) nucleic acid molecules and proteins and uses therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |